SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element

Journal of Virology

Volumn 70, Issue 2, 1996, Pages 1163-1172

  McNally, Lisa M ^a   McNally, Mark T ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY; VIRUS DNA; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; CROSS LINKING; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; RNA SPLICING; ROUS SARCOMA ONCOVIRUS; ULTRAVIOLET RADIATION; VIRAL GENETICS; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 0030061154     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.2.1163-1172.1996     Document Type: Article

References (48)

1. Amendt, B. A., D. Hesslein, L.-J. Chang, and C. M. Stoltzfus. 1994. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first fas coding exon of human immunodeficiency virus type 1 Mol. Cell Biol. 14:3960-3970.
2. Amendt, B. A., Z.-H. Si, and C. M. Stoltzfus. 1995 Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol. Cell. Biol. 15:4606-4615
3. Amendt, B. A., S. B. Simpson, and C. M. Stoltzfus. 1995 Inhibition of RNA splicing at the Rous sarcoma virus src 3′ splice site is mediated by an interaction between a negative cis element and a chicken embryo fibroblast nuclear factor. J. Virol. 69:5068-5076
4. Arrigo, S., and K. Beemon. 1988. Regulation of Rous sarcoma virus RNA splicing and stability Mol. Cell Biol. 8:4858-4867.
5. Arrigo, S. J., and I. S. Y. Chen. 1991. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif vpr. and env/vpu 2 mRNAs. Genes Dev 5:808-819.
6. Berberich, S. L., and C. M. Stoltzfus. 1991. Mutations in the regions of the Rous sarcoma virus 3′ splice sites: implications for regulation of alternative splicing. J. Virol 65:2640-2546.
7. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
8. Coffin, J. M. 1990. Retroviridae and their replication, p. 1437-1500. In B. N. Fields and D. M. Knipe (ed.), Virology, 2nd ed. Raven Press, New York.
9. Cook, C. R., and M. T. McNally. Unpublished data.
10. Cullen, B. R. 1992. Mechanism of action of regulatory proteins encoded by complex retroviruses. Annu. Rev. Microbiol. 45:219-250.
11. Dignam, J. D., R. M. Lebovitz, and R. D. Reeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
12. Eperon, I. C., D. C. Ireland, R. A. Smith, A. Mayeda, and A. R. Krainer. 1993. Pathways for selection of 5′ splice sites by U1 snRNPs and SF2/ASF. EMBO J. 12:3607-3617.
13. Fu, X.-D. 1995 The superfamily of arginine/serine-rich splicing factors. RNA 1:663-680.
14. Fu, X.-D., R. A. Katz, A. M. Skalka, and T. Maniatis. 1991 The role of branchpoint and 3′ exon sequences in the control of balanced splicing of avian retrovirus RNA. Genes Dev. 5:211-220.
15. Fu, X.-D., A. Mayeda, T. Maniatis, and A. R. Krainer. 1992. General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5′ and 3′ splice site selection. Proc. Natl. Acad. Sci. USA 89:11224-11228.
16. Garcia-Blanco, M. A., S. F. Jamison, and P. A. Sharp. 1989. Identification and purification of a 62,000-dalton protein that binds specifically to the polypyrimidme tract of introns. Genes Dev. 3:1874-1886
17. Ge, H., P. Zou, and J. L. Manley. 1991. Primary structure of the human splicing factor ASF reveak similarities with Drosophila regulators. Cell 66:373-382.
18. Gilliam, A. C., and J. A. Steitz. 1993. Rare scleroderma autoantibodies to the U11 small nuclear ribonucleoprotein and to the trimethylguanosine cap of U small nuclear RNAs. Proc Natl. Acad. Sci. USA 90:6781-6785.
19. Gontarek, R. R., M. T. McNally, and K. Beemon. 1993 Mutation of an RSV intronic element abolishes both U11/U12 snRNP binding and negative regulation of splicing Genes Dev 7:1926-1936
20. Hall, S. L. and R. A. Padgett. 1994. Conserved sequences in a rare class of eukaryotic nuclear introns with non-consensus splice sites J. Mol. Biol. 239:357-365.
21. Henikoff, S. 1984 Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. Gene 28:351-359.
22. Katz, R. A., M. Kotler, and A. M. Skalka. 1988. cis-acting intron mutations that affect the efficiency of avian retroviral RNA splicing: implications for mechanisms of control. J. Virol. 62:2686-2695.
23. Katz, R. A., and A. M. Skalka. 1990. Control of retroviral RNA splicing through maintenance of suboptimal processing signals. Mol. Cell Biol. 10:695-704.
24. Kjems, J., and P. A. Sharp. 1993. The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assembly. J. Virol. 67:4769-4776.
25. Krainer, A. R., A. Mayeda, K. Kozak, and G. Binns. 1991 Functional expression of cloned human splicing factor SF2: homology to RNA-binding proteins. U1 70K, and Drosophila splicing regulators. Cell 66:383-394
26. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685
27. Malim, M. H., and B. R. Cullen. 1993. Rev and fate of pre-mRNA in the nucleus, implications for the regulation of RNA processing in eukaryotes. Mol. Cell. Biol. 13:6180-6189
28. Martarano, L., R. Stephens, N. Rice, and D. Derse. 1994. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing. J. Virol. 68:3102-3111.
29. McNally, M. T., and K. Beemon. 1992. Intronic sequences and 3′ splice sites control Rous sarcoma virus RNA splicing J. Virol. 66:6-11.
30. McNally, M. T., and K. Beemon. Unpublished observation.
31. McNally, M. T., R. R. Gontarek, and K. Beemon. 1991. Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing. Virology 185:99-108.
32. Mellon, D. A., P. A. Krieg, M. R. Rebagliati, T. Maniatis, K. Zinn, and M. R. Green. 1984 Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promotor. Nucleic Acids Res. 12:7035-7056.
33. Meric, C., and P.-F. Spahr. 1986. Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging. J Virol. 60:450-459
34. Michaud, S., and R. Reed. 1991. An ATP-independent complex commits pre-mRNA to the mammalian spliceosome assembly pathway. Genes Dev 5:2534-2546.
35. Saiki, R. K., D. H. Gelfand, S. Stoffel, S. Scharf, R. H. Higuchi, G. T. Horn, K. B. Mullis, and H. A. Erlich. 1988. Primer-directed enzymatic amplification with a thermostable DNA polymerase. Science 239:487-191.
36. Schwartz, S., B. K. Felber, and G. N. Pavlakis. 1992. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J Virol 66:150-159.
37. Schwartz, D. E., R. Tizard, and W. Gilbert. 1983. Nucleotide sequence of Rous sarcoma virus RNA. Cell 32:853-869.
38. Spikes, D. A., J. Kramer, P. M. Bingham, and K. Van Doren. 1994 SWAP pre-mRNA splicing regulators are a novel, ancient protein family sharing a highly conserved sequence motif with the prp21 family of constitutive splicing factors. Nucleic Acids Res. 22:4510-4519.
39. Staffs, A., and A. Cochrane. 1995. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 15:4597-4605.
40. Staknis, D., and R. Reed. 1994. SR proteins promote the first specific recognition of pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. Mol Cell Biol. 14:7670-7682.
41. Stoltzfus, C. M. 1988. Synthesis and processing of avian sarcoma retrovirus RNA. Adv. Virus Res 35:1-38.
42. Stoltzfus, C. M., and S. J. Fogarty. 1989. Multiple regions in the Rous sarcoma virus src gene intron act in cis to affect accumulation of unspliced RNA J. Virol. 63:1669-1676.
43. Sun, Q., A. Mayeda, R. K. Hampson, A. R. Krainer, and F. M. Rottman. 1993. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev. 7:2598-2608.
44. Tacke, R., and J. L. Manley. 1995. The human splicing factors ASF SF2 and SC35 possess distinct, functionally significant RNA binding specificities EMBO J. 14:3540-3551.
45. Wang, J., and J. L. Manley. 1995. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways RNA 1:335-346.
46. Zahler, A. M., W. S. Lane, J. A. Stolk, and M. B. Roth. 1992. SR proteins a conserved family of pre-mRNA splicing factors. Genes Dev 6:837-847
47. Zhang, L., and C. M. Stoltzfus. 1995 A suboptimal 3′ splice site is necessary for efficient replication of Rous sarcoma virus. Virology 206:1099-1107
48. Zou, P., and J. L. Manley. 1994 The human splicing factor ASF/SF2 can specifically recognize pre-mRNA 5′ splice sites. Proc. Natl. Acad. Sci. USA 91:3363-3367.